Vorherr H
Klin Wochenschr. 1979 Feb 1;57(3):101-9. doi: 10.1007/BF01476049.
Prolactin, as a "broad spectrum hormone", has been described to exert also vascular and renal actions in laboratory animals and in humans. However, prolactin preparations of various species are contaminated with neurohypophysial hormones (ADH, oxytocin) which possess vascular and renal activities. Antisera against ADH, oxytocin and prolactin are rather specific inactivators of the biologic activity of the respective hormone; the oxytocinasevasopressinase system of pregnancy plasma destroys ADH and oxytocin. Incubation-identification procedures with antisera against ADH, oxytocin and prolactin and with pregnancy plasma revealed that changes in blood pressure, urine flow and urinary osmolarity cannot be ascribed to prolactin per se but to the ADH impurity of prolactin preparations. Furthermore, recent metabolic studies in normally hydrated, overhydrate and dehydrated animals and humans have shown that prolactin does not affect renal water and electrolyte excretion. Thus, earlier reports on vascular and renal activity of prolactin in laboratory animals and humans should be viewed with great caution. Elimination of neurohypophysial hormone impurities of prolactin preparations by incubation with either ADH and oxytocin antisera or with pregnancy plasma provides techniques for better assessment of the real biologic effects of the prolactin molecule.
催乳素作为一种“广谱激素”,在实验动物和人类中也被描述为具有血管和肾脏作用。然而,不同物种的催乳素制剂都被神经垂体激素(抗利尿激素、催产素)污染,而这些激素具有血管和肾脏活性。抗抗利尿激素、催产素和催乳素的抗血清是各自激素生物活性相当特异的灭活剂;妊娠血浆中的催产素酶-血管加压素酶系统会破坏抗利尿激素和催产素。用抗抗利尿激素、催产素和催乳素的抗血清以及妊娠血浆进行的孵育鉴定程序表明,血压、尿流量和尿渗透压的变化不能归因于催乳素本身,而是由于催乳素制剂中的抗利尿激素杂质。此外,最近对正常水合、水合过多和脱水的动物及人类进行的代谢研究表明,催乳素不影响肾脏对水和电解质的排泄。因此,对于早期关于实验动物和人类中催乳素血管和肾脏活性的报道应持非常谨慎的态度。通过与抗抗利尿激素和催产素抗血清或妊娠血浆孵育来去除催乳素制剂中的神经垂体激素杂质,为更好地评估催乳素分子的真正生物学效应提供了技术手段。